|
Volumn 131, Issue 27, 2006, Pages 1541-1545
|
Focal segmental glomerulosclerosis (FSGS): Molecular defects and clinical relevance;Fokal-segmentale glomerulosklerose (FSGS): Molekulare defekte und klinische relevanz
|
Author keywords
Focal segmental glomerulosclerosis; Nephrotic syndrome; Podocytes
|
Indexed keywords
CANCER GROWTH FACTOR;
STEROID;
CD2 ASSOCIATED PROTEIN;
CD2-ASSOCIATED PROTEIN;
CYTOSKELETON PROTEIN;
MEMBRANE PROTEIN;
PODOCIN;
SIGNAL PEPTIDE;
SIGNAL TRANSDUCING ADAPTOR PROTEIN;
TRANSFORMING GROWTH FACTOR BETA;
ARTICLE;
CLINICAL ASSESSMENT;
FOCAL GLOMERULOSCLEROSIS;
HISTOPATHOLOGY;
HUMAN;
IN VITRO STUDY;
NEPHROTIC SYNDROME;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PODOCYTE;
SIGNAL TRANSDUCTION;
STATISTICAL SIGNIFICANCE;
ANIMAL;
DISEASE MODEL;
GENETICS;
MUTATION;
PATHOLOGY;
PHYSIOLOGY;
REVIEW;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ANIMALS;
CYTOSKELETAL PROTEINS;
DISEASE MODELS, ANIMAL;
GLOMERULOSCLEROSIS, FOCAL SEGMENTAL;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
MEMBRANE PROTEINS;
MUTATION;
PODOCYTES;
SIGNAL TRANSDUCTION;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 33746473628
PISSN: 00120472
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2006-947793 Document Type: Article |
Times cited : (2)
|
References (5)
|